Rebalix
Xtrackers · sheet of 4 September 2026
Xtrackers · sheet of 4 September 2026ETF sheet · official issuer and register data
Xtrackers S P 500 Swap Ii UCITS ETF 1d
IE000FO05UG4 · IE000FO05UG4 · USD · domicile Ireland
Equity · United States · Large capSFDR art. 6 (inferred)
Index tracked: S&P 500 INDEX (USD)
- TER
- 0.04%+ trans. 0.00%
- Fund size
- 5 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- —white list not published
- Replication
- Synthetic (swap)
- Income
- Distributingsemi-annual
Launch 9 Jul 2025 · costs from the KID as of 2 Sept 2026 · 247 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to track the performance, before fees and expenses, of the S&P 500 Index (index) which is designed to reflect the performance of shares of 500 companies representing all major US industries.
DESCRIPTION OF INDEX:
The index contains shares of large companies traded on certain eligible US exchanges. A company’s weighting in the index depends on its relative size based on the combined value of a company’s readily available shares as compared to other companies on the…
Performance since series start (in euro) — base 100
9 Jul 2025 → 3 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +22.4% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +26.1% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.71% | 12.71% | — |
| Max drawdown | −9.15% | −9.15% | — |
| Sharpe | 1.34 | 1.34 | — |
| Sortino | 1.95 | 1.95 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE000FO05UG4 · IE000FO05UG41
RebalixIE000FO05UG4 · IE000FO05UG4 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +9.89% | +9.74% | +0.14% |
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.3143 USD (0.74% of NAV) · 7 months of history: not a full year · last ex-date 19 Aug 2026
| Year | Payments | Total (USD) |
|---|---|---|
| 2026 | 2 | 0.3143 |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 247 securities · top-10 weight = 38.2%
| Top holdings | Weight |
|---|---|
| 5.6% | |
| 5.6% | |
| 4.7% | |
| 4.0% | |
| 4.0% | |
| 3.3% | |
| 3.2% | |
| 2.9% | |
| 2.8% | |
| 2.0% |
Listing venues
ESMA register (FIRDS) and official exchange lists
XISP · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000FO05UG4
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000FO05UG4
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE000FO05UG4 · IE000FO05UG42